What is 10x Technology?
10x Technology LLC operates at the intersection of material science and medical device manufacturing. The company specializes in the production of precision micro and nano-structured substrates, utilizing a proprietary roll-to-roll process that ensures structural integrity without the risk of shrinkage or distortion. Their core value proposition lies in the ability to deliver stress-free, high-precision components that meet the rigorous standards of the pharmaceutical and medical device industries.
A primary focus for the company is the development of microneedle arrays, which represent a significant advancement in transdermal drug delivery. By offering a pain-free alternative to traditional hypodermic syringes, 10x Technology is positioning itself as an essential partner for pharmaceutical firms looking to improve patient compliance and drug delivery efficacy. Their end-to-end service model, which spans from initial product design to full-scale manufacturing, provides a comprehensive solution for clients navigating the complexities of medical device commercialization.
How much funding has 10x Technology raised?
10x Technology has raised a total of $4.4M across 2 funding rounds:
Unspecified
$3M
Unspecified
$1.4M
Unspecified (2012): $3M, investors not publicly disclosed
Unspecified (2013): $1.4M led by Cornerstone Angels
Key Investors in 10x Technology
Cornerstone Angels
Cornerstone Angels is a membership-based private angel investment group that bridges the gap between start-up and institutional capital. They provide financial backing and mentorship to high-growth ventures, particularly within the Midwest region.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for 10x Technology?
With the recent strategic investment, 10x Technology is well-positioned to accelerate its operational roadmap. The focus will likely shift toward expanding manufacturing capacity to meet the growing demand for transdermal delivery systems. As the company scales, it will likely prioritize the optimization of its roll-to-roll processes to maintain cost-efficiency while adhering to stringent regulatory requirements in the medical sector. Future growth will be driven by the successful commercialization of its microneedle array technology and the potential for further partnerships within the global pharmaceutical landscape.
See full 10x Technology company page
